Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks in Patients With Chronic Constipation

NCT00765882 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00765882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00765882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks in Patients With Chronic Constipation
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
August 31, 2009
Enrollment
633 (actual)
Sites
108

Conditions

As the registry lists them; a condition with its own page is linked.

chronic constipation